Protonated nanostructured aluminosilicate (NSAS) reduces plasma cholesterol concentrations and atherosclerotic lesions in apolipoprotein E deficient mice fed a high cholesterol and high fat diet

Lipids in Health and Disease

Volumn 8, Issue , 2009, Pages

  Sivak, Olena ^a   Darlington, Jerry ^b   Gershkovich, Pavel ^a   Constantinides, Panayiotis P ^c   Wasan, Kishor M ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b AMCOL International Corp   (United States)

^c Biopharmaceutical and Drug Delivery Consulting   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HYPOCHOLESTEROLEMIC AGENT; NANOMATERIAL; NANOSTRUCTURED ALUMINOSILICATE; SILICATE; SITOSTANOL; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; ALUMINOSILICIC ACID; ALUMINUM SILICATE; APOLIPOPROTEIN E; BENTONITE; METAL NANOPARTICLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ATHEROSCLEROSIS; ARTICLE; BLOOD SAMPLING; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DISEASE COURSE; DRUG ACTIVITY; DRUG DELIVERY SYSTEM; LIPID DIET; MOUSE; NONHUMAN; TRIACYLGLYCEROL BLOOD LEVEL; ANIMAL; AORTA; AORTA DISEASE; ATHEROSCLEROSIS; BLOOD; C57BL MOUSE; CHEMICAL STRUCTURE; CHOLESTEROL INTAKE; DISEASE MODEL; DRUG EFFECT; FAT INTAKE; GENETICS; MOUSE MUTANT;

ANIMALIA; MUS;

ALUMINUM SILICATES; ANIMALS; ANTICHOLESTEREMIC AGENTS; AORTA; AORTIC DISEASES; APOLIPOPROTEINS E; ATHEROSCLEROSIS; BENTONITE; BODY WEIGHT; CHOLESTEROL; CHOLESTEROL, DIETARY; DIETARY FATS; DISEASE MODELS, ANIMAL; METAL NANOPARTICLES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOLECULAR STRUCTURE; TRIGLYCERIDES;

EID: 69049115301     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-8-30     Document Type: Article

References (12)

1. Regulation of intestinal cholesterol absorption. DQ Wang, Annu Rev Physiol 2007 69 221 248 10.1146/annurev.physiol.69.031905.160725 17002594
2. Sitosterolemia - a rare disease. Are elevated plant sterols an additional risk factor? T Sudhop K von Bergmann, Z Kardiol 2004 93 921 928 10.1007/s00392-004-0165-2 15599566
3. Plasma sitosterol elevations are associated with an increased incidence of coronary events in men: results of a nested case-control analysis of the Prospective Cardiovascular Munster (PROCAM) study. G Assmann P Cullen J Erbey DR Ramey F Kannenberg H Schulte, Nutr Metab Cardiovasc Dis 2006 16 13 21 10.1016/j.numecd.2005.04.001 16399487
4. Phytosterols and vascular disease. MD Patel PD Thompson, Atherosclerosis 2006 186 12 19 10.1016/j.atherosclerosis.2005.10.026 16325823
5. Ezetimibe-associated adverse effects: what the clinician needs to know. M Florentin EN Liberopoulos MS Elisaf, Int J Clin Pract 2008 62 88 96 18173814
6. Montmorillonite ameliorates hyperthyroidism of rats and mice attributed to its adsorptive effect. Y Cai XF Meng YX Cao H Lu SF Zhu LZ Zhou, Eur J Pharmacol 2006 551 156 161 10.1016/j.ejphar.2006.08.053 17027745
7. Chronic toxicological evaluation of dietary NovaSil clay in Sprague-Dawley rats. E Afriyie-Gyawu J Mackie B Dash M Wiles J Taylor H Huebner L Tang H Guan JS Wang T Phillips, Food Addit Contam 2005 22 259 269 10.1080/02652030500110758 16019794
8. Reducing human exposure to aflatoxin through the use of clay: a review. TD Phillips E Afriyie-Gyawu J Williams H Huebner NA Ankrah D Ofori-Adjei P Jolly N Johnson J Taylor A Marroquin-Cardona L Xu L Tang JS Wang, Food Addit Contam Part A Chem Anal Control Expo Risk Assess 2008 25 134 145 18286403
9. Inhibition of intestinal absorption of cholesterol by surface-modified nanostructured aluminosilicate compounds. P Gershkovich J Darlington O Sivak PP Constantinides KM Wasan, J Pharm Sci 2009 98 2390 2400 10.1002/jps.21616 19090562
10. Disodium ascorbyl phytostanyl phosphate reduces plasma cholesterol concentrations and atherosclerotic lesion formation in apolipoprotein E-deficient mice. T Lukic KM Wasan D Zamfir MH Moghadasian PH Pritchard, Metabolism 2003 52 425 431 10.1053/meta.2003.50084 12701053
11. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. AS Plump JD Smith T Hayek K Aalto-Setala A Walsh JG Verstuyft EM Rubin JL Breslow, Cell 1992 71 343 353 10.1016/0092-8674(92)90362-G 1423598
12. Method of manufacturing polymer-grade clay for use in nanocomposites. M Clarey J Edwards SJ Tsipursky GW Beall DD Eisenhour, US Patent No. 6050509 2000